BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20074571)

  • 1. Autophagy-mediated antigen processing in CD4(+) T cell tolerance and immunity.
    Klein L; Münz C; Lünemann JD
    FEBS Lett; 2010 Apr; 584(7):1405-10. PubMed ID: 20074571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing immunity through autophagy.
    Münz C
    Annu Rev Immunol; 2009; 27():423-49. PubMed ID: 19105657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in CD4+ T-cell immunity and tolerance.
    Lünemann JD; Münz C
    Cell Death Differ; 2009 Jan; 16(1):79-86. PubMed ID: 18636073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy and antigen presentation.
    Münz C
    Cell Microbiol; 2006 Jun; 8(6):891-8. PubMed ID: 16681832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and MHC class II presentation of antigens targeted for macroautophagy.
    Schmid D; Münz C
    Methods Mol Biol; 2008; 445():213-25. PubMed ID: 18425453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.
    Dengjel J; Schoor O; Fischer R; Reich M; Kraus M; Müller M; Kreymborg K; Altenberend F; Brandenburg J; Kalbacher H; Brock R; Driessen C; Rammensee HG; Stevanovic S
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7922-7. PubMed ID: 15894616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC class II-presentation of antigen by autophagy].
    Kumamoto Y; Iwasaki A
    Tanpakushitsu Kakusan Koso; 2008 Dec; 53(16 Suppl):2286-91. PubMed ID: 21038623
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export.
    Riedel A; Nimmerjahn F; Burdach S; Behrends U; Bornkamm GW; Mautner J
    Eur J Immunol; 2008 Aug; 38(8):2090-5. PubMed ID: 18624354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in MHC class II presentation of endogenous antigens.
    Gannagé M; Münz C
    Curr Top Microbiol Immunol; 2009; 335():123-40. PubMed ID: 19802563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in MHC class II antigen processing.
    Strawbridge AB; Blum JS
    Curr Opin Immunol; 2007 Feb; 19(1):87-92. PubMed ID: 17129719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy as an immune defense mechanism.
    Deretic V
    Curr Opin Immunol; 2006 Aug; 18(4):375-82. PubMed ID: 16782319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy in MHC class II presentation: sampling from within.
    Menéndez-Benito V; Neefjes J
    Immunity; 2007 Jan; 26(1):1-3. PubMed ID: 17241953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection.
    Aguirre K; Miller S
    Glia; 2002 Aug; 39(2):184-8. PubMed ID: 12112369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroautophagy in immunity and tolerance.
    Gannagé M; Münz C
    Traffic; 2009 Jun; 10(6):615-20. PubMed ID: 19192248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune recognition and effector function in subsets of CD4 T cells.
    Janeway CA; Yagi J; Rojo J; Portoles P; Carding S; Luqman M; Bottomly K
    Princess Takamatsu Symp; 1988; 19():193-208. PubMed ID: 2908353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.
    Nimmerjahn F; Milosevic S; Behrends U; Jaffee EM; Pardoll DM; Bornkamm GW; Mautner J
    Eur J Immunol; 2003 May; 33(5):1250-9. PubMed ID: 12731050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive selection of CD4+ T cells mediated by MHC class II-bearing stromal cell in the thymic cortex.
    Bill J; Palmer E
    Nature; 1989 Oct; 341(6243):649-51. PubMed ID: 2571938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.